These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35137140)

  • 1. Approach to the Patient With Lipodystrophy.
    Fourman LT; Grinspoon SK
    J Clin Endocrinol Metab; 2022 May; 107(6):1714-1726. PubMed ID: 35137140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial lipodystrophy: Clinical presentation and treatment.
    Mosbah H; Vatier C; Vigouroux C
    Ann Endocrinol (Paris); 2024 Jun; 85(3):197-200. PubMed ID: 38871513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy resistant diabetes mellitus and lipodystrophy: leptin therapy leads to improvement].
    Jazet IM; Jonker JT; Wijngaarden MA; Lamb H; Smelt AH
    Ned Tijdschr Geneeskd; 2013; 157(4):A5482. PubMed ID: 23343738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to diagnose a lipodystrophy syndrome.
    Vantyghem MC; Balavoine AS; Douillard C; Defrance F; Dieudonne L; Mouton F; Lemaire C; Bertrand-Escouflaire N; Bourdelle-Hego MF; Devemy F; Evrard A; Gheerbrand D; Girardot C; Gumuche S; Hober C; Topolinski H; Lamblin B; Mycinski B; Ryndak A; Karrouz W; Duvivier E; Merlen E; Cortet C; Weill J; Lacroix D; Wémeau JL
    Ann Endocrinol (Paris); 2012 Jun; 73(3):170-89. PubMed ID: 22748602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance, acanthosis nigricans, and hypertriglyceridemia.
    Eberting CL; Javor E; Gorden P; Turner ML; Cowen EW
    J Am Acad Dermatol; 2005 Feb; 52(2):341-4. PubMed ID: 15692481
    [No Abstract]   [Full Text] [Related]  

  • 6. Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
    Akinci G; Akinci B
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):74-8. PubMed ID: 26556498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of lipodystrophy syndromes.
    Akinci G; Celik M; Akinci B
    Presse Med; 2021 Nov; 50(3):104085. PubMed ID: 34728268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function.
    Bruder-Nascimento T; Kress TC; Belin de Chantemele EJ
    F1000Res; 2019; 8():. PubMed ID: 31656583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin replacement therapy in the management of lipodystrophy syndromes.
    Vigouroux C; Mosbah H; Vatier C
    Ann Endocrinol (Paris); 2024 Jun; 85(3):201-204. PubMed ID: 38871500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Options for Lipodystrophy in Children.
    Mainieri F; Tagi VM; Chiarelli F
    Front Endocrinol (Lausanne); 2022; 13():879979. PubMed ID: 35600578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.
    Vatier C; Vantyghem MC; Storey C; Jéru I; Christin-Maitre S; Fève B; Lascols O; Beltrand J; Carel JC; Vigouroux C; Bismuth E
    Curr Med Res Opin; 2019 Mar; 35(3):543-552. PubMed ID: 30296183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of Lipodystrophy.
    Lightbourne M; Brown RJ
    Endocrinol Metab Clin North Am; 2017 Jun; 46(2):539-554. PubMed ID: 28476236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature.
    Misra A; Garg A
    Medicine (Baltimore); 2003 Mar; 82(2):129-46. PubMed ID: 12640189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary disease of adipose tissue: When to think about and how to evaluate it in clinical practice?
    Vatier C; Vigouroux C; Mosbah H
    Ann Endocrinol (Paris); 2024 Jun; 85(3):190-194. PubMed ID: 38871502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of lipodystrophy: a step-by-step approach.
    Araújo-Vilar D; Santini F
    J Endocrinol Invest; 2019 Jan; 42(1):61-73. PubMed ID: 29704234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin.
    Diker-Cohen T; Cochran E; Gorden P; Brown RJ
    J Clin Endocrinol Metab; 2015 May; 100(5):1802-10. PubMed ID: 25734254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipodystrophies.
    Garg A
    Am J Med; 2000 Feb; 108(2):143-52. PubMed ID: 11126308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report.
    Pedicelli S; de Palma L; Pelosini C; Cappa M
    Ital J Pediatr; 2020 Oct; 46(1):158. PubMed ID: 33099310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy.
    Park JY; Chong AY; Cochran EK; Kleiner DE; Haller MJ; Schatz DA; Gorden P
    J Clin Endocrinol Metab; 2008 Jan; 93(1):26-31. PubMed ID: 17940115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and Cellular Bases of Lipodystrophy Syndromes.
    Zammouri J; Vatier C; Capel E; Auclair M; Storey-London C; Bismuth E; Mosbah H; Donadille B; Janmaat S; Fève B; Jéru I; Vigouroux C
    Front Endocrinol (Lausanne); 2021; 12():803189. PubMed ID: 35046902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.